Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2560 participants
OBSERVATIONAL
2022-09-01
2022-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is designed to be a multicenter, observational, cross-sectional, and descriptive study. It will be conducted in 50 centers in 12 regions of Turkey. The study does not include any interventional or treatment procedures.
At the end of the study, clinicians will have up-to-date information about predictors of mortality in CCU patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients
NCT05549739
Predictors of Heart Failure After ST-segment Elevation Myocardial Infarction (HF-EXPRESS)
NCT02650934
The Assessment of Survival After In-hospital Cardiac Arrest for 2 Years in Tertiary Hospital
NCT03484559
The Effect of Preoperative Values on Mortality in Patients Undergoing Open Heart Surgery
NCT04741555
Brain-Induced Neurotrophic Factor Levels in Patients Undergoing Coronary Artery Bypass Surgery
NCT04250935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There has not been any large-scale epidemiological study on coronary care patients in Turkey recently. Therefore, up-to-date information in this group of patients is lacking. In particular, significant reductions in mortality and morbidity are expected, thanks to improved medical and interventional facilities. In the light of current data, the investigators designed a large-scale study to document mortality rates and predictors in CCU patients.
In this study, the investigators will include consecutive patients admitted to CCU with cardiovascular indications in all participating centers. Patients will be followed and treated by experienced cardiologists and no further experimental intervention will be planned. In the first part of the study, the investigators will record in-hospital mortality rates and try to identify the best predictors. In the second part of the MORCOR-TURK trial which will have a cohort design, the investigators will follow the successfully discharged patients for 1 year. At the end of the follow-up, investigators will assess the risk factors and predictors of cardiovascular events as secondary endpoints.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coronary Care Patients
All patients admitted to coronary care unit with cardiovascular diseases.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalized with cardiovascular diseases
* individuals (or relatives for unconscious patients) who gave written informed consent
Exclusion Criteria
* rejecting to sign an informed consent
* hospitalized to CCU by other departments with noncardiac indications
* patients with active severe noncardiac chronic disease (chronic obstructive pulmonary disease, systemic diseases, and malignancy)
* no vital signs despite adequate cardiopulmonary resuscitation during hospitalization
* rejected to stay in CCU and discharged with his/her own request
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Afyonkarahisar Health Sciences University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
İbrahim Ersoy, MD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fatih Kahraman, MD
Role: STUDY_DIRECTOR
Kutahya Health Sciences University Evliya Celebi Research and Training Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Afyonkarahisar Health Sciences University
Afyonkarahisar, , Turkey (Türkiye)
Kutahya Evliya Celebi Research and Training Hospital
Kütahya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ratcliffe JA, Wilson E, Islam S, Platsman Z, Leou K, Williams G, Lucido D, Moustakakis E, Rachko M, Bergmann SR. Mortality in the coronary care unit. Coron Artery Dis. 2014 Jan;25(1):60-5. doi: 10.1097/MCA.0000000000000043.
Filizcan U, Kurc E, Cetemen S, Soylu O, Aydogan H, Bayserke O, Yilmaz M, Uyarel H, Ergelen M, Orhan G, Ugurlucan M, Eren E, Yekeler I. Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting. Angiology. 2011 Jan;62(1):68-73. doi: 10.1177/0003319710369103. Epub 2010 May 12.
Hayiroglu MI, Keskin M, Uzun AO, Yildirim DI, Kaya A, Cinier G, Bozbeyoglu E, Yildirimturk O, Kozan O, Pehlivanoglu S. Predictors of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Complicated With Cardiogenic Shock. Heart Lung Circ. 2019 Feb;28(2):237-244. doi: 10.1016/j.hlc.2017.10.023. Epub 2017 Nov 14.
Campanile A, Castellani C, Santucci A, Annunziata R, Tutarini C, Reccia MR, Del Pinto M, Verdecchia P, Cavallini C. Predictors of in-hospital and long-term mortality in unselected patients admitted to a modern coronary care unit. J Cardiovasc Med (Hagerstown). 2019 May;20(5):327-334. doi: 10.2459/JCM.0000000000000785.
Taylan G, Kaya C, Ozbek M, Kurt F, Kacmaz Y, Akkaya F, Kahraman F, Yilmaz AS. Short-Term Prognosis of Elderly Patients Admitted to the Coronary Care Unit: A Subgroup Analysis of the MORCOR-TURK (Mortality and Morbidity in Coronary Care Units in Turkiye) Trial. Turk Kardiyol Dern Ars. 2024 Sep;52(6):411-419. doi: 10.5543/tkda.2024.51282.
Kahraman F, Ersoy I, Yilmaz AS, Atici A, Tekin AM, Acar B, Kaya C, Kara F, Kurt F, Avci Demir F, Cerik IB, Yilmaz I, Adali MK, Yeni M, Tascanov MB, Yenercag M, Sahin M, Duz R, Gulasti S, Omur SE, Topuz S, Hidayet S, Kacmaz Y, Aygul N. Rationale, Design, and Methodology of the MORCOR-TURK Trial: Predictors of In-hospital MORtality in CORonary Care Patients in Turkey. Anatol J Cardiol. 2023 May;27(5):258-265. doi: 10.14744/AnatolJCardiol.2022.2824.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3450
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.